Technical Analysis for CEMI - Chembio Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 3.9 -2.74% -0.11
CEMI closed down 2.74 percent on Friday, January 17, 2020, on 6.07 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CEMI trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -2.74%
Lower Bollinger Band Walk Weakness -2.74%
Below Lower BB Weakness -2.74%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Medicine Medical Specialties Immunology Infectious Diseases Antibodies Immune System Antibody Diagnostic Tests Medical Tests HIV Technology Products HIV/Aids Ortho Clinical Diagnostics Retail Establishments Diagnosis Of Hiv/Aids

Is CEMI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.9
52 Week Low 3.8
Average Volume 97,847
200-Day Moving Average 5.78
50-Day Moving Average 4.46
20-Day Moving Average 4.63
10-Day Moving Average 4.47
Average True Range 0.35
ADX 21.44
+DI 16.79
-DI 33.32
Chandelier Exit (Long, 3 ATRs ) 4.36
Chandelier Exit (Short, 3 ATRs ) 4.84
Upper Bollinger Band 5.37
Lower Bollinger Band 3.89
Percent B (%b) 0.01
BandWidth 31.92
MACD Line -0.13
MACD Signal Line -0.03
MACD Histogram -0.1054
Fundamentals Value
Market Cap 48.01 Million
Num Shares 12.3 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -5.49
Price-to-Sales 4.04
Price-to-Book 4.83
PEG Ratio -0.47
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.23
Resistance 3 (R3) 4.23 4.13 4.18
Resistance 2 (R2) 4.13 4.04 4.13 4.16
Resistance 1 (R1) 4.01 3.99 3.96 4.01 4.14
Pivot Point 3.91 3.91 3.88 3.91 3.91
Support 1 (S1) 3.79 3.82 3.74 3.79 3.66
Support 2 (S2) 3.69 3.77 3.69 3.64
Support 3 (S3) 3.57 3.69 3.63
Support 4 (S4) 3.57